User menu

Lenalidomide in relapsed refractory myeloma patients: impact of previous response to bortezomib and thalidomide on treatment efficacy. Results of a medical need program in Belgium.

Bibliographic reference Delforge, M ; Michiels, A ; Doyen, Chantal ; Kentos, A ; Van Droogenbroeck, J ; et. al. Lenalidomide in relapsed refractory myeloma patients: impact of previous response to bortezomib and thalidomide on treatment efficacy. Results of a medical need program in Belgium.. In: Acta clinica Belgica, Vol. 66, no.5, p. 371-5 (2011)
Permanent URL http://hdl.handle.net/2078.1/123491